Fernández Martínez Ana María, Cordero Carnicero Patricia, Pérez Álvarez Andrea, Cuesta Marcos M Teresa, Romero Alonso David, Baldi Sebastián
Vascular and Interventional Radiology Department, University Hospital of León, Calle Altos de Nava, SN, 24080, León, Spain.
Area of Research and Innovation Department, University Hospital of León, León, Spain.
Cardiovasc Intervent Radiol. 2025 Jun 5. doi: 10.1007/s00270-025-04078-8.
To evaluate the clinical outcomes of transcatheter arterial embolization (TAE) for adhesive capsulitis (AC) resistant to conventional treatments.
This is a retrospective analysis performed between January 2015 and December 2024. TAE was performed with a suspension of imipenem/cilastatin sodium in contrast agent. Subjects were assessed before, 1 week, 1, 3, 6 and 12 months after the procedure using the pain visual analogue scale (VAS) and the joint balance of Constant-Murley score (CMS). Demographic variables, risk factors, technical aspects and adverse events were also evaluated.
The study included 128 TAE procedures in 118 patients with AC. 84/118 [71.7%] women; mean age 52.4 ± 8.7 years old. One patient was lost to follow-up. Six months after TAE, significant improvements were observed in terms of pain reduction 7.8 vs. 2.2, P < .001 and regarding mobility in flexion and abduction, respectively (90.1° vs. 143.3°, P < .001; 79.6° vs. 128.8°, P < .001). No major adverse events occurred. Clinical improvement was documented in 115/128 (89.8%) at 12-month follow-up.
TAE achieved pain reduction and functional improvement in patients with adhesive capsulitis refractory to conservative treatments.
Level 4, Case Series.
评估经导管动脉栓塞术（TAE）治疗对传统治疗耐药的粘连性肩周炎（AC）的临床疗效。
这是一项于2015年1月至2024年12月期间进行的回顾性分析。采用亚胺培南/西司他丁钠混悬液与造影剂进行TAE。在术前、术后1周、1、3、6和12个月，使用疼痛视觉模拟量表（VAS）和Constant-Murley评分（CMS）的关节平衡对受试者进行评估。还评估了人口统计学变量、危险因素、技术方面和不良事件。
该研究纳入了118例AC患者的128例TAE手术。84/118 [71.7%]为女性；平均年龄52.4±8.7岁。1例患者失访。TAE术后6个月，在疼痛减轻方面观察到显著改善（7.8对2.2，P <.001），在屈曲和外展活动度方面也分别有显著改善（90.1°对143.3°，P <.001；79.6°对128.8°，P <.001）。未发生重大不良事件。在12个月的随访中，115/128（89.8%）记录到临床改善。
TAE在保守治疗难治的粘连性肩周炎患者中实现了疼痛减轻和功能改善。
4级，病例系列。
